One more virtual congress, as we continue to engage in with Plastic Surgeons across the world. This November 13th and 14th, GC Aesthetics will be exhibiting at the GÄCD Virtual Meeting.
GÄCD is a organisation whose main objectives are to further develop scientific and practical knowledge and experience in the field of aesthetic medicine, to promote the next generation and to inform the public. The Society for Aesthetic Surgery Germany pursues exclusively and directly charitable purposes.
Stop by our virtual booth
We are beyond excited to engage once more thru our virtual booth, which will be available on the 13th and the 14th of November and you’ll be able to check out our full range of pre-surgery, surgery and post-surgery products – we recommend stopping by to learn more about the newest launches from GC Aesthetics: PERLETM, HydroCone and our GCA Comfort Plus Warranty.
Take advantage of the chat feature at the booth to talk directly with our GC Aesthetics team members. We’d love to answer your burning questions and guide you as to which GC Aesthetics products can bring the most value to you, your patients and your practice.
Our Head of Marketing, Fara Naomi Macías, will speak about our most recent launch, PERLETM, under the title: The importance of advancing Smooth Opaque Breast Implant surfaces.
You can register for this amazing event using the link below.
Access the complete program here:
We hope to see you there!
About GC Aesthetics
GC Aesthetics is an established global medical technology company that develops, manufactures in-house and markets a comprehensive range of proprietary aesthetic products that empower patients to feel confident and secure in their personal journey.
Throughout 40 years of commercial presence, GCA has been dedicated to advancing the science of medical aesthetics and delivering high-quality silicone breast implants under its premium Nagor and Eurosilicone brands, primarily for breast augmentation and breast reconstructive surgery. We have sold more than 3 million implants across 70 countries and our products are supported by published 10-year clinical data demonstrating compelling safety and clinical effectiveness.
The company’s vertically integrated strategy enables exceptional clinical, operational and commercial performance, which allows GCA to provide competitively differentiated products to physicians and patients. Through a culture of continuous innovation and dedication to customer-responsiveness, GCA has established itself as a leading provider of medical aesthetics solutions and the partner-of-choice for patients seeking to improve their lives.